Direkt zum Inhalt
Merck

Selection for constrained peptides that bind to a single target protein.

Nature communications (2021-11-05)
Andrew M King, Daniel A Anderson, Emerson Glassey, Thomas H Segall-Shapiro, Zhengan Zhang, David L Niquille, Amanda C Embree, Katelin Pratt, Thomas L Williams, D Benjamin Gordon, Christopher A Voigt
ZUSAMMENFASSUNG

Peptide secondary metabolites are common in nature and have diverse pharmacologically-relevant functions, from antibiotics to cross-kingdom signaling. Here, we present a method to design large libraries of modified peptides in Escherichia coli and screen them in vivo to identify those that bind to a single target-of-interest. Constrained peptide scaffolds were produced using modified enzymes gleaned from microbial RiPP (ribosomally synthesized and post-translationally modified peptide) pathways and diversified to build large libraries. The binding of a RiPP to a protein target leads to the intein-catalyzed release of an RNA polymerase σ factor, which drives the expression of selectable markers. As a proof-of-concept, a selection was performed for binding to the SARS-CoV-2 Spike receptor binding domain. A 1625 Da constrained peptide (AMK-1057) was found that binds with similar affinity (990 ± 5 nM) as an ACE2-derived peptide. This demonstrates a generalizable method to identify constrained peptides that adhere to a single protein target, as a step towards "molecular glues" for therapeutics and diagnostics.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ammoniumbicarbonat, ReagentPlus®, ≥99.0%
Sigma-Aldrich
Guanidin -hydrochlorid, ≥98%
Sigma-Aldrich
4-Isopropylbenzoesäure, ≥96%
Sigma-Aldrich
N-(β-Ketocaproyl)-L-Homoserinlacton, ≥98%
Supelco
Anhydrotetracyclin -hydrochlorid, VETRANAL®, analytical standard